TCM Prescription: Xiao Shi Shun Qi Tablets



Prescription Description
Prescription IDTCMFx6301
Pinyin NameXiao Shi Shun Qi Pian
Chinese Name消食顺气片
English NameXiao Shi Shun Qi Tablets
Function Description积滞
IndicationsDyspepsia
Disease ICD-11 Category MD92 [Dyspepsia, 消化不良 ];
Human Tissues Associated with IndicationSpleen, Intestine, Stomach
ReferenceCFDA
Reference Book/linkhttp://samr.cfda.gov.cn/WS01/CL0001/
Prescription Components
Component ID Latin Name Chinese Name Component Quantity Barcode
TCMH2640 Valeriana jatamansii 蜘蛛香 TCMH2640
TCMH216 Fructus tsaoko 草果 TCMH216 GQ118666
TCMH1026 Gallus gallus domesticus 鸡内金 TCMH1026 ACLB009-06
TCMH1595 NA 糯米 TCMH1595
Reference: CFDA

Targeted Human Proteins by the Ingredients of Prescription

Target ID Gene Symbol Target Name Target Class Uniprot ID
TCMT223 AKR1B1 Aldose reductase Oxidoreductase P15121
TCMT295 MMP1 Matrix metalloproteinase-1 Hydrolase P03956
TCMT306 MMP2 Matrix metalloproteinase-2 Hydrolase P08253
TCMT321 MMP9 Matrix metalloproteinase 9 Hydrolase P14780


Targeted Pathogenic Microbes by the Ingredients of Prescription

Target ID Target Name
TCMT1218 Staphylococcus aureus
TCMT1251 Candida albicans
TCMT1253 Penicillium chrysogenum
TCMT1346 Helicobacter pylori
TCMT1454 Bacillus subtilis
TCMT1462 Streptococcus mutans

Gene Ontology Associated to Targeted Human Proteins

GO Term GO Name Enriched Genes Log10 Adjusted P-value


KEGG Pathways Associated to Targeted Human Proteins

KEGG Pathway ID Enriched Genes Log10 Adjusted P-value


Target Exprsssion in Healthy Human Tissues (protein & mRNA level)

Protein expression data was from the "Human Proteome Map" dataset
mRNA expression data was from the "GTEx" dataset



Average Target Expression (Fold Change) in Multiple Disease Conditions

Fold Change with Corresponding Normal Samples
Click each cell within the heatmap to access gene expression of individual patient samples
Data Section
Select to Download
1. General Information of Prescription  
2. Putative Targets  
3. Activity & References for Filtering Putative Targets  
4. GO & Pathway